Taysha Gene Therapies

TSHA · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 9 days ago

Total Revenue

$1.99M

Previous year: $1.11M

+78.6%

EPS

-$0.09

Previous year: -$0.09

+0.0%

R&D expenses

$20.1M

Previous year: $15.1M

+33.6%

G&A expenses

$8.6M

Previous year: $7.34M

+17.2%

Total operating expenses

$28.7M

Previous year: $22.4M

Loading...

Taysha Gene Therapies

Unlock previous datapoints

Upgrade

Taysha Gene Therapies

Unlock previous datapoints

Upgrade

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.17B

P/E Ratio

-11.57

Sector

N/A

Industry

N/A

52-Week High

$5.88

52-Week Low

$1.11

R&D expenses

$20.1M

G&A expenses

$8.6M

Total operating expenses

$28.7M

Net loss per share

-$0.09

W.A. shares outstanding

297.99M

Products

Get in Touch

Resources

Taysha Gene Therapies

Taysha Gene Therapies

Taysha Gene Therapies

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics